Skip to main content
GL Pharm Tech Corp. logo

GL Pharm Tech Corp. — Investor Relations & Filings

Ticker · 204840 ISIN · KR7204840003 KO Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2026-03-26 Declaration of Voting R…
Country KR South Korea
Listing KO 204840

About GL Pharm Tech Corp.

http://www.glpt.co.kr/

GL Pharm Tech Corp. is a pharmaceutical company specializing in the development of incrementally modified drugs (IMDs). The company focuses on creating improved versions of existing pharmaceutical products by utilizing advanced drug formulation and delivery technologies. Its core mission is to enhance the therapeutic value and safety of marketed drugs, with a specific emphasis on reducing side effects and improving patient convenience. GL Pharm Tech is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials to support the commercialization of its enhanced pharmaceutical products.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회결과” (Annual General Meeting Results) and provides detailed voting outcomes for each agenda item (approval of financial statements, directors’ remuneration limit, auditor’s remuneration limit), including voting percentages and pass/fail status. It also lists record date, meeting date, and related disclosures. This matches a Declaration of Voting Results & Voting Rights Announcement.
2026-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from a Korean company (GL PharmTech) announcing the submission of its audit report. It contains key financial highlights, audit opinions, and financial statements for the fiscal year. While it provides financial data, it is a summary announcement of the audit report submission rather than the full, multi-page audited financial statement document itself. Therefore, it fits the definition of a Report Publication Announcement (RPA). FY 2025
2026-03-18 Korean
사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for GL PharmTech, covering the fiscal years 2024 and 2025. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. Since it contains comprehensive financial statements and audit results for a full fiscal year, it is classified as an Annual Report (10-K). FY 2025
2026-03-18 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for GL PharmTech. It outlines the date, location, agenda items (approval of financial statements, director/auditor compensation), and voting reference dates. This document serves as the official notification and solicitation of shareholder participation for an upcoming meeting, which falls under the category of Proxy Solicitation & Information Statement.
2026-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for GL Pharm Tech. It contains the meeting agenda, date, location, and detailed management information including board activities, remuneration, and financial statements (balance sheets, income statements, etc.) for the 12th fiscal year. This type of document is standard for providing shareholders with the necessary information to vote at an AGM, which falls under the Proxy Solicitation & Information Statement category.
2026-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (DART system) used by companies to solicit proxies from shareholders for an upcoming Annual General Meeting (AGM). It includes details about the meeting, the purpose of the solicitation, and financial statements as reference material for shareholders. This falls under the category of Proxy Solicitation & Information Statement.
2026-03-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.